论文部分内容阅读
肺炎支原体(mycoplasma pneumoniae,MP)是常见儿童呼吸系统感染性疾病中最重要的致病微生物之一,其感染引起的肺炎支原体肺炎(MPP)约占儿童社区获得性肺炎的10%~40%。近年来大量临床实践及研究发现[1],一部分患儿给予阿奇霉素等大环内酯类抗生素正规用药1周或以上,但其症状和肺部影像学仍无明显改善,病情加重或迁延不愈,甚至出现一些严重的并发症,导致难治性肺炎支原体肺炎(refractory
Mycoplasma pneumoniae (MP) is one of the most important pathogenic microorganisms in respiratory diseases of common children. Its infection causes about 10% -40% of children’s community-acquired pneumonia. In recent years, a large number of clinical practice and research found that [1], part of the children given azithromycin and other macrolide antibiotics for 1 week or more regular medication, but the symptoms and pulmonary imaging still no significant improvement, aggravation or delayed healing , And even some serious complications, leading to refractory mycoplasma pneumonia (refractory